Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7081500rdf:typepubmed:Citationlld:pubmed
pubmed-article:7081500lifeskim:mentionsumls-concept:C0011206lld:lifeskim
pubmed-article:7081500lifeskim:mentionsumls-concept:C0683150lld:lifeskim
pubmed-article:7081500pubmed:issue6lld:pubmed
pubmed-article:7081500pubmed:dateCreated1982-7-19lld:pubmed
pubmed-article:7081500pubmed:abstractTextFourteen patients receiving routine doses of amitriptyline developed plasma drug concentrations above 300 ng/ml. Of the 7 patients with plasma levels above 450 ng/ml, 6 developed a drug-induced delirium as opposed to none of the 7 with levels below 450 ng/ml. Thus, this adverse effect could be avoided by monitoring levels and reducing dosage when appropriate.lld:pubmed
pubmed-article:7081500pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7081500pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7081500pubmed:languageenglld:pubmed
pubmed-article:7081500pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7081500pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7081500pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7081500pubmed:statusMEDLINElld:pubmed
pubmed-article:7081500pubmed:monthJunlld:pubmed
pubmed-article:7081500pubmed:issn0002-953Xlld:pubmed
pubmed-article:7081500pubmed:authorpubmed-author:PreskornS HSHlld:pubmed
pubmed-article:7081500pubmed:authorpubmed-author:SimpsonSSlld:pubmed
pubmed-article:7081500pubmed:issnTypePrintlld:pubmed
pubmed-article:7081500pubmed:volume139lld:pubmed
pubmed-article:7081500pubmed:ownerNLMlld:pubmed
pubmed-article:7081500pubmed:authorsCompleteYlld:pubmed
pubmed-article:7081500pubmed:pagination822-3lld:pubmed
pubmed-article:7081500pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7081500pubmed:meshHeadingpubmed-meshheading:7081500-...lld:pubmed
pubmed-article:7081500pubmed:meshHeadingpubmed-meshheading:7081500-...lld:pubmed
pubmed-article:7081500pubmed:meshHeadingpubmed-meshheading:7081500-...lld:pubmed
pubmed-article:7081500pubmed:meshHeadingpubmed-meshheading:7081500-...lld:pubmed
pubmed-article:7081500pubmed:meshHeadingpubmed-meshheading:7081500-...lld:pubmed
pubmed-article:7081500pubmed:meshHeadingpubmed-meshheading:7081500-...lld:pubmed
pubmed-article:7081500pubmed:meshHeadingpubmed-meshheading:7081500-...lld:pubmed
pubmed-article:7081500pubmed:meshHeadingpubmed-meshheading:7081500-...lld:pubmed
pubmed-article:7081500pubmed:meshHeadingpubmed-meshheading:7081500-...lld:pubmed
pubmed-article:7081500pubmed:meshHeadingpubmed-meshheading:7081500-...lld:pubmed
pubmed-article:7081500pubmed:meshHeadingpubmed-meshheading:7081500-...lld:pubmed
pubmed-article:7081500pubmed:year1982lld:pubmed
pubmed-article:7081500pubmed:articleTitleTricyclic-antidepressant-induced delirium and plasma drug concentration.lld:pubmed
pubmed-article:7081500pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7081500pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7081500lld:pubmed